Spencer Pharmaceutical Inc. (SPPH)
SPPH Stock Price Chart
Explore Spencer Pharmaceutical Inc. interactive price chart. Choose custom timeframes to analyze SPPH price movements and trends.
SPPH Company Profile
Discover essential business fundamentals and corporate details for Spencer Pharmaceutical Inc. (SPPH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
7 Feb 2023
Employees
—
CEO
Maximilien Arella
Description
Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases. The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications. It has operations primarily in North America and Europe. The company was incorporated in 1998 and is based in Boston, Massachusetts.
SPPH Financial Timeline
Browse a chronological timeline of Spencer Pharmaceutical Inc. corporate events including earnings releases, dividend announcements, and stock splits.
SPPH Stock Performance
Access detailed SPPH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.